Selective progesterone receptor modulator with iron supplementation

This page covers all Selective progesterone receptor modulator with iron supplementation drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Progesterone receptor (PR); iron supplementation (non-receptor target).

Targets

Progesterone receptor (PR); iron supplementation (non-receptor target)

Phase 3 pipeline (1)

• PGL4001 (ulipristal) and iron · PregLem SA · Gynecology / Women's Health
  Ulipristal is a selective progesterone receptor modulator that suppresses ovulation and alters the endometrium, while iron supplementation addresses iron deficiency anemia.

Patent intelligence

• selective progesterone receptor modulator with iron supplementation patent landscape — aggregated cliff calendar, attackable patents, originator estates